Not applicableLooking for participantsNCT05657652What this trial is testingCAV Regimen for R/R Ph- B-ALLWho this might be right forAcute Lymphoblastic Leukemia The First Affiliated Hospital of Soochow University 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07157514What this trial is testingRadioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AMLWho this might be right forAcute LeukemiaMyeloid LeukemiaAcute Myelogenous Leukemia+8 more Actinium Pharmaceuticals 306
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Early research (Phase 1)Study completedNCT03955783What this trial is testingVenetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic MalignanciesWho this might be right forDiffuse Large B-cell LymphomaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma Sanjay Mohan 78
Early research (Phase 1)Study completedNCT03886831What this trial is testingPRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesWho this might be right forRelapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more Prelude Therapeutics Incorporated 232
Very early researchNot Yet RecruitingNCT04609241What this trial is testingCD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's LymphomaWho this might be right forRelapsed and/or Refractory Acute Lymphoblastic LeukemiaRelapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma Zhejiang University 72
Early research (Phase 1)Active Not RecruitingNCT04684563What this trial is testingHuCART19-IL18 in CD19+ CancersWho this might be right forChronic Lymphocytic LeukemiaNon-hodgkin LymphomaAcute Lymphoblastic Leukemia University of Pennsylvania 72
Early research (Phase 1)Ended earlyNCT01186328What this trial is testingEZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)Who this might be right forLymphoblastic Leukemia, AcuteLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, T Cell+1 more Therapeutic Advances in Childhood Leukemia Consortium 6
Not applicableStudy completedNCT00049465What this trial is testingStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571What this trial is testingThis is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Who this might be right forAcute Lymphobkastic LeukemiaB Cell Lymphoma Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Early research (Phase 1)Study completedNCT05665530What this trial is testingPRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic MalignanciesWho this might be right forAggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)+9 more Prelude Therapeutics Incorporated 86
Early research (Phase 1)Temporarily pausedNCT06447987What this trial is testingHumanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic LeukemiaWho this might be right forRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia City of Hope Medical Center 24
Early research (Phase 1)Study completedNCT00710528What this trial is testingDose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic MalignanciesWho this might be right forChronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)+1 more Gilead Sciences 192
Testing effectiveness (Phase 2)WithdrawnNCT02028039What this trial is testingIPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)Who this might be right forLeukemia M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06137118What this trial is testingAZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaWho this might be right forB-cell Acute Lymphoblastic Leukemia (B-ALL) AstraZeneca 255
Testing effectiveness (Phase 2)Looking for participantsNCT03136146What this trial is testingCombination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaWho this might be right forRecurrent Acute Lymphoblastic LeukemiaRecurrent Adult Lymphoblastic LymphomaRecurrent Burkitt Leukemia+8 more M.D. Anderson Cancer Center 42
Early research (Phase 1)UnknownNCT03671460What this trial is testingCD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.Who this might be right forB-cell Acute Lymphoblastic Leukemia Tianjin Mycure Medical Technology Co., Ltd 18
Testing effectiveness (Phase 2)Study completedNCT00040846What this trial is testingAlemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00006348What this trial is testingOndansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+7 more Alliance for Clinical Trials in Oncology 100